AAPL 251.035 -1.7822% MSFT 423.585 -1.6131% NVDA 136.1201 -0.6495% GOOGL 189.835 -1.5174% GOOG 191.12 -1.5048% AMZN 219.61 -1.8503% META 587.695 -2.0198% AVGO 232.666 -3.7576% TSLA 422.24 -2.1823% TSM 198.81 -1.3986% LLY 774.5 -1.107% V 313.84 -1.5126% JPM 238.625 -1.0553% UNH 504.0 -1.1745% NVO 86.23 -1.3048% WMT 90.76 -0.9819% LVMUY 131.1 -0.9145% XOM 106.02 -0.432% LVMHF 655.0 -1.4289% MA 524.84 -1.3829%
Company Overview: Allakos Inc. (NASDAQ: ALLK) is a clinical-stage biotechnology company, which is engaged in the development of therapeutics that target immunomodulatory receptors present on immune effector cells involved in allergy, inflammatory and proliferative diseases. This Report covers the Price Action, Technical Indicators Analysis along with the Target Levels, Stop Loss, Support Levels, Resistance Levels, and Recommendation on stock.
US Markets Round-Up
This week, the Russell 3000 index, an important benchmark of the US stock market across market capitalizations, started the week on a negative note and continued the momentum. The index made low of 3349.74 during the week and settled at 3350.01 with a week-to-date (WTD) loss of ~3.352 percent on Dec 19, 2024. Other major indices, such as S&P 500 and NASDAQ Composite displayed downside move for the week. On Dec 20, 2024, the S&P 500 index settled at 5867.07 with a WTD loss of ~ 0.09 percent, while the NASDAQ Composite Index settled at 19372.76 with a WTD loss of ~2.78 percent.
Having understood the US market performance over the week, taking cues from major global news, and based on technical analysis of the Russell 3000 index for the upcoming week, now let’s have a look at the one US-listed stock to pick from the technical standpoint. Noted below recommendation is based on the entry price, target prices, and stop-loss for Allakos Inc. (NASDAQ: ALLK) for the next 2-4 weeks duration:
Xxxxxx Xxxxxx Xxxxxx
Xxxxxx Xxxxxx
Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx .
Xxxxxx Xxxxxx Xxxxxx Xxxxxx & Xxxxxx
Xxxxxx Xxxxxx
Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx .
Xxxxxx
Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx .
Enter your details below and our team will help you to decide if this product is best for you.
Kalkine Equities LLC, with Delaware File Number 4697384, Foreign Qualification Registration in California File Number 202109211078, and Texas File Number 805521396, is authorized to provide general advice only. The information on https://kalkine.com/ does not take into account any of your investment objectives, financial situation or needs. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. The link to our Terms and Conditions and Privacy Policy has been provided for your reference. On the date of publishing the reports (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.
Copyright © 2024 Krish Capital Pty Ltd. All rights reserved.
US 
AU
UK
CA
NZ
Please wait processing your request...